JIM - Journal of Internal Medicine

A peer-reviewed journal in the field of internal medicine.
Impact Factor 7.6. ✉️ [email protected]

[JIM - Journal of Internal Medicine @JInternMed]

Want to learn more about chronic kidney disease? Read this recently published article!

➡️One estimated glomerular filtration rate, many diseases: What remains beyond filtration-based classification of chronic kidney disease? https://t.co/WaA9TYn5R4

#CKD #kidney #disease #KDIGO

[Ivan Velázquez @Nephro_Ivan]

Muy buena imagen que reflexiona a cerca de los diferentes subtipos de enfermedades que llevan a ERC y su impacto en deterioro de TFGe
👇🏼👇🏼👇🏼
@JInternMed

[JIM - Journal of Internal Medicine @JInternMed]

Tea for the heart! The German health portal for pharmacists and pharmacies highlights: #Tea consumption is associated with lower #cardiovascular disease risk.

🫖 Also, read the original article in Journal of Internal Medicine!

https://t.co/p3dMlugvCj https://t.co/e6BpPa0QPw

[Abdelhamed Hamdy @Abdelhamed012]

One estimated glomerular filtration rate, many diseases: What remains beyond filtration-based classification of chronic kidney disease? https://t.co/dHoLkOx9iT

[JIM - Journal of Internal Medicine @JInternMed]

New article to read! Pharyngotonsillitis, aphthous stomatitis, and adenitis precede #familial #Mediterranean #fever by two decades.

➡️ May be a clinical cue to consider familial Mediterranean fever in at-risk populations.

🔗 https://t.co/4UbHf115Ap

#tonsillitis @bengurionu

[JIM - Journal of Internal Medicine @JInternMed]

Welcome to read the Editor´s Choice in November!

➡️Recent advances in PMOS, formerly PCOS, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk.

🔗https://t.co/LQgCM0lcGW

#PMOS #PCOS #cardiovascular

[JIM - Journal of Internal Medicine @JInternMed]

New Letter to the Editor to read! Authors reply: European genomic: An untapped opportunity to strengthen the fight against #antimicrobial #resistance.

🔗 https://t.co/XeHqIesCLl

👉Also, read the Letters it is commenting on! https://t.co/STkoPM9BzM, https://t.co/w3a51Hjy4d

[JIM - Journal of Internal Medicine @JInternMed]

New Letter to the Editor to read! Regarding: European genomic: An untapped opportunity to strengthen the fight against #antimicrobial #resistance.

➡️https://t.co/STkoPMa9pk

👉Also, read the article it is commenting on: https://t.co/w3a51Hk5TL

#AMR

[JIM - Journal of Internal Medicine @JInternMed]

We’re happy that the recently published article 'Habitual tea consumption is associated with lower cardiovascular disease risk' has received a lot of attention.

👉 https://t.co/IWHJRqOLRi

#cardiovascular #teaconsumption

[Wiley Clinical and Health @WileyHealth]

📰 #TrendingResearchTuesday:

A new study published in the Journal of Internal Medicine reveals that drinking tea may help protect against #CardiovascularDisease 🍵🫖

@CNN covers the findings: https://t.co/AtBCw0t1Bq

@JInternMed

[JIM - Journal of Internal Medicine @JInternMed]

New review! A global overview of #mortality #inequalities between countries and by ranked #socio-#economic circumstances within countries

➡️Health inequalities are seen between populations, social groups and across populations ranked by social position

🔗https://t.co/ZgWY9GpXoj

[JIM - Journal of Internal Medicine @JInternMed]

New Review to read! One estimated glomerular filtration rate, many diseases.

➡️ What remains beyond filtration-based classification of chronic kidney disease?

🔗 https://t.co/WaA9TYn5R4

#CKD #glomerularfiltration #kidneydisease #albuminuria #KDIGO #nephrology

[Keith Siau @drkeithsiau]

Yet more data on the benefits of drinking tea ☕️ 👍

📸: https://t.co/rH9Y2LaL4B

[JIM - Journal of Internal Medicine @JInternMed]

New Perspective to read! #Periodontitis and systemic disease: A clinical perspective.

➡️ Increasing evidence associates periodontitis with systemic inflammatory conditions, particularly atherosclerotic #cardiovascular disease.

🔗 https://t.co/7mPi3r0amB

#atherosclerosis

[JIM - Journal of Internal Medicine @JInternMed]

New Research Letter! Anti-Ku positivity in primary #Sjögren's disease is associated with a more severe disease course.

���️Primary Sjögren’s disease is a common autoimmune disease with systemic manifestations in 40%–60% of patients.

🔗https://t.co/obJyEUzpSI

#autoimmune #AntiKu

[JIM - Journal of Internal Medicine @JInternMed]

In CNN: regarding an article published today: https://t.co/XnVqOS4qZh

👉Also, read the article: https://t.co/IWHJRqOLRi

#cardiovascular #teaconsumption #internalmedicine

[JIM - Journal of Internal Medicine @JInternMed]

News Release! Can drinking tea help protect against cardiovascular disease?, via @EurekAlert! https://t.co/JOKkXlmGj7

[JIM - Journal of Internal Medicine @JInternMed]

New article! Habitual #tea consumption is associated with lower #cardiovascular disease risk.

➡️Tea consumption combined with non-smoking and high physical activity was associated with the lowest risk.

🔗https://t.co/IWHJRqOLRi

#physicalactivity #smoking #teaconsumption

[JIM - Journal of Internal Medicine @JInternMed]

New Perspective! Interacting climatic, environmental, biologic and socio-economic drivers of the global #dengue expansion.

➡️Dengue is the most rapidly expanding mosquito-borne viral disease worldwide.
➡️Over 11,000 deaths in 2024.

🔗 https://t.co/jHtcZWdyOa

#infectiousdisease

[JIM - Journal of Internal Medicine @JInternMed]

New review to read! Treatment of #hyperphagia and #obesity in Prader–Willi syndrome.

➡️ Studies of the first approved treatment of hyperphagia in PWS, have shown promising results, particularly in managing severe hyperphagia.

🔗 https://t.co/jEZfRsfBdP

#PraderWillisyndrome

[JIM - Journal of Internal Medicine @JInternMed]

The November issue is now online!

👉Read our latest articles!

🔗https://t.co/AE0c7sroqP

#insomnia #gut #microbiome #cardiovascular #kidneydisease #snus #nicotine #dialyses #Hypocholesterolemia #liverdisease #PMOS #PCOS #longevity #ageing #fasting #multimorbidity #statins

[JIM - Journal of Internal Medicine @JInternMed]

New review! #GLP-1 receptor agonists and serious adverse events.

➡️ Appraises evidence regarding seven serious adverse events linked to GLP-1 receptor agonists.
➡️ Evidence, uncertainty and clinical implications.

🔗https://t.co/vGVbtIZYYQ

#diabetesmellitus #obesity